12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Deals

PeptiDream, GlaxoSmithKline deal

GlaxoSmithKline partnered with PeptiDream to discover and develop peptide therapeutics against the pharma's targets using the biotech's Peptide Discovery Platform System (PDPS). PDPS enables incorporation of modified unnatural amino acids into mRNA display peptide...

Read the full 146 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >